Impact of cosmetic result on selection of surgical treatment in patients with localized prostate cancer - Abstract

OBJECTIVES: To analyze the effect of cosmetic outcome as an isolated variable in patients undergoing surgical treatment based on the incision used in the 3 variants of radical prostatectomy: open (infraumbilical incision and Pfannestiel incision) and laparoscopic, or robotic (6 ports) surgery.

PATIENTS AND METHODS: 612 male patients 40 to 70 years of age with a negative history of prostate disease were invited to participate. Each patient was evaluated by questionnaire accompanied by a set of 6 photographs showing the cosmetic appearance of the 3 approaches, with and without undergarments. Participants ranked the approaches according to preference, on the basis of cosmesis. We also recorded demographic variables: age, body mass index, marital status, education level, and physical activity.

RESULTS: Of the 577 patients who completed the questionnaries, the 6-port minimally invasive approach represents the option preferred by 52% of the participants, followed by the Pfannestiel incision (46%), and the infraumbilical incision (11%), respectively. The univariate and multivariate analyses did not show statistically significant differences when comparing the approach preferred by the patients and the sub-analyses for demographic variables, except for patients who exercised who preferred the Pfannestiel incision (58%) instead of minimally invasive approach (42%) with statistically significant differences.

CONCLUSION: The minimally invasive approach was the approach of choice for the majority of patients in the treatment of prostate cancer. The Pfannestiel incision represents an acceptable alternative. More research and investment may be necesary to improve cosmetic outcomes.

Written by:
Rojo MA, Martinez-Salamanca JI, Maestro MA, Galarza IS, Rodriguez JC.   Are you the author?
Urology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain; Urology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain; Urology Department, Hospital Universitario Infanta Leonor, Madrid, Spain; Urology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain.

Reference: JSLS. 2014 Oct;18(4). pii: e2014.00024.
doi: 10.4293/JSLS.2014.00024

 
PubMed Abstract
PMID: 25516703

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe